<- Go Home
Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Market Cap
$9.3B
Volume
939.0K
Cash and Equivalents
$124.6M
EBITDA
$367.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$960.5M
Profit Margin
61.63%
52 Week High
$179.00
52 Week Low
$125.94
Dividend
N/A
Price / Book Value
11.84
Price / Earnings
44.16
Price / Tangible Book Value
14.67
Enterprise Value
$9.7B
Enterprise Value / EBITDA
25.76
Operating Income
$321.1M
Return on Equity
24.99%
Return on Assets
10.20
Cash and Short Term Investments
$124.6M
Debt
$485.9M
Equity
$788.9M
Revenue
$1.6B
Unlevered FCF
$344.2M
Sector
Health Care Equipment and Supplies
Category
N/A